Connect Biopharma Holdings (CNTB) Current Leases (2020 - 2026)

Connect Biopharma Holdings (CNTB) has reported Current Leases for 7 consecutive years, with $406000.0 the latest figure, recorded in Q1 2026.

• Quarterly Current Leases fell 54.89% year-over-year to $406000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $406000.0 (down 54.89% YoY) and the FY2025 annual result came in at $322000.0, up 109.09% from the prior year.
• Current Leases advanced to $406000.0 in Q1 2026 per CNTB's latest filing, from $322000.0 in the prior quarter.
• Over the last five years, Current Leases for CNTB reached as high as $900000.0 in Q1 2025 and fell as low as $154000.0 in Q4 2024.
• A 5-year average of $334994.7 and a median of $285000.0 in 2023 frame the typical range for Current Leases.
• Annual changes were most pronounced in 2025 — Current Leases surged 109.09% — and 2026, when it tumbled 54.89%.
• Year by year, Current Leases stood at $181941.7 in 2022, then jumped by 56.64% to $285000.0 in 2023, then plunged by 45.96% to $154000.0 in 2024, then jumped by 109.09% to $322000.0 in 2025, then climbed by 26.09% to $406000.0 in 2026.
• According to Business Quant data, Current Leases over the past three periods registered $406000.0, $322000.0, and $336000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.